Etova 300 Tablet

Etova 300 Tablet is a pain-relieving medicine. It effectively alleviates pain and inflammation in conditions like rheumatoid arthritis, osteoarthritis, and acute pain.

Etova 300 Tablet should be taken in the dose and duration as advised by your doctor. It should be taken with food or milk to prevent stomach upset. Inform your doctor if you have any history of heart disease or stroke.
Vomiting, stomach pain, nausea, and indigestion are some of the common side effects that might be observed on taking this medicine. It may also cause dizziness, drowsiness, or visual disturbances. Your doctor may regularly monitor your kidney function, liver function, and levels of blood components if you are taking this medicine for long-term treatment. Long-term use may lead to serious complications such as stomach bleeding and kidney problems.

• Pain relief

Pain relief
Etova 300 Tablet belongs to a group of medicines called nonsteroidal anti- inflammatory drugs (NSAIDs). It is used for short-term relief of pain, inflammation, and swelling in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis.

Take it as it is prescribed to get the most benefit. Do not take more or for longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Etova LP

• Vomiting
• Nausea
• Dizziness
• Diarrhea
• Heartburn
• Abdominal pain
• Flatulence
• Dyspepsia

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the gel. Wash your hands after applying, unless hands are the affected area.

Etova 300 Tablet is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).

• You have been prescribed Etova 300 Tablet to relieve pain and inflammation.

• Take it with food or milk to prevent upset stomach.

• Take it as per the dose and duration prescribed by your doctor. Long term use may lead to serious complications such as stomach bleeding and kidney problems.

• It may cause dizziness, drowsiness or visual disturbances. Use caution while driving or doing anything that requires concentration.

• Avoid consuming alcohol while taking Etova 300 Tablet as it can cause excessive drowsiness and increase your risk of stomach problems.

• Inform your doctor if you have a history of heart disease or stroke.

• Your doctor may regularly monitor your kidney function, liver function and levels of blood components, if you are taking this medicine for long-term treatment.

Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 627.

Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 985-86.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 518.

Drugs.com. Etodolac. [Accessed 02 Apr. 2019] (online) Available from:

Etodolac. Princeton, New Jersey: Aesgen Inc.; 1997. [Accessed 02 Apr. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from: